End Stage Renal Disease
Polycystic Kidney Disease
Chronic Kidney Disease
- An Open-Label Phase 2 Study to Evaluate the Safety, Tolerability, and Effect on Albuminuria of MZE829 in Adults with Proteinuric Chronic Kidney Disease and the APOL1 High Risk Genotype
- ExPAND Study: “Expanding and Promoting Alternative Care and Knowledge in Decision-Making; Expanding choice for people with kidney disease”
- A Phase 2/3 Adaptive, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Adult and Pediatric Subjects With APOL1-mediated Proteinuric Kidney Disease
Completed Clinical Trials
- RAINIER Study: "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Povetacicept in Adults with Immunoglobulin A Nephropathy
- The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository
- CASCADE FH Registry
- A Study of the Prevalence of Apolipoprotein L1(APOL1) Alleles Among Individuals With Proteinuric Kidney Disease Who Are of Recent African Ancestry or Geographic Origin
- RENAL AID: Repository of Novel Analytes Leading to Autoimmune, Inflammatory, and Diabetic Nephropathies
- Clinical Care of Autosomal Dominant Polycystic Kidney Disease: Retrospective Analysis and Prospective PKD Genotyping
- Fructose-induced Hepatic De Novo Lipogenesis in Adolescents with Obesity
- Procalcitonin And Brain Natriuretic Peptides In Patients With Chronic Kidney Disease
- Study of HemoCare™ Hemodialysis System For Home Nocturnal Dialysis In Participants With ESRD
- An Open Label To Study To Allow Participants Continuous Use Of The HemoCare™ Hemodialysis System
- A Double-blind Randomized Parallel Group Study of the Efficacy and Safety of Tesevatinib in Subjects with Autosomal Dominant Polycystic Kidney Disease
- A Clinical Trial of Water Therapy for Autosomal Dominant Polycystic Disease
- Anxiety and Symptom Burden in Hemodialysis Patients
- Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients with Hyperkalemia Receiving Patiromer
For general information regarding the Clinical Research Program, please contact:
Betty-Jane Sloan, MA, CCRC, Clinical Research Manager
504 East 74th Street, 5th Floor
New York, NY 10021
Email: bjsloan@nyp.org
Phone: 646-317-0701